188 related articles for article (PubMed ID: 27694895)
1. Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer.
Witt AE; Lee CW; Lee TI; Azzam DJ; Wang B; Caslini C; Petrocca F; Grosso J; Jones M; Cohick EB; Gropper AB; Wahlestedt C; Richardson AL; Shiekhattar R; Young RA; Ince TA
Oncogene; 2017 Mar; 36(12):1707-1720. PubMed ID: 27694895
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase 7: a signalling hub controlling development, inflammation, metabolism and disease.
Wang Y; Abrol R; Mak JYW; Das Gupta K; Ramnath D; Karunakaran D; Fairlie DP; Sweet MJ
FEBS J; 2023 Jun; 290(11):2805-2832. PubMed ID: 35303381
[TBL] [Abstract][Full Text] [Related]
3. Genetic dissection of histone deacetylase requirement in tumor cells.
Haberland M; Johnson A; Mokalled MH; Montgomery RL; Olson EN
Proc Natl Acad Sci U S A; 2009 May; 106(19):7751-5. PubMed ID: 19416910
[TBL] [Abstract][Full Text] [Related]
4. HDAC7: a promising target in cancer.
Liu C; Zheng D; Pu X; Li S
Front Oncol; 2024; 14():1327933. PubMed ID: 38487728
[TBL] [Abstract][Full Text] [Related]
5. Future Prospects in Breast Cancer Research - Cancer Stem Cells.
Wolbers F; Franke HR; Klaase JM; Brinkhuis M; van den Berg A; Vermes I
EJIFCC; 2012 Oct; 23(3):80-6. PubMed ID: 27683420
[TBL] [Abstract][Full Text] [Related]
6. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
[TBL] [Abstract][Full Text] [Related]
7. HDAC7 promotes the oncogenicity of nasopharyngeal carcinoma cells by miR-4465-EphA2 signaling axis.
Li QG; Xiao T; Zhu W; Yu ZZ; Huang XP; Yi H; Lu SS; Tang YY; Huang W; Xiao ZQ
Cell Death Dis; 2020 May; 11(5):322. PubMed ID: 32376822
[TBL] [Abstract][Full Text] [Related]
8. HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.
Caslini C; Hong S; Ban YJ; Chen XS; Ince TA
Oncogene; 2019 Sep; 38(39):6599-6614. PubMed ID: 31375747
[TBL] [Abstract][Full Text] [Related]
9. Stabilized Peptide HDAC Inhibitors Derived from HDAC1 Substrate H3K56 for the Treatment of Cancer Stem-Like Cells
Wang D; Li W; Zhao R; Chen L; Liu N; Tian Y; Zhao H; Xie M; Lu F; Fang Q; Liang W; Yin F; Li Z
Cancer Res; 2019 Apr; 79(8):1769-1783. PubMed ID: 30842103
[TBL] [Abstract][Full Text] [Related]
10. HDAC7-mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells.
Cutano V; Di Giorgio E; Minisini M; Picco R; Dalla E; Brancolini C
Mol Oncol; 2019 Aug; 13(8):1651-1668. PubMed ID: 31081251
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously.
Hii LW; Chung FF; Soo JS; Tan BS; Mai CW; Leong CO
Breast Cancer Res Treat; 2020 Feb; 179(3):615-629. PubMed ID: 31784862
[TBL] [Abstract][Full Text] [Related]
12. The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos.
Shao R; Suzuki T; Suyama M; Tsukada Y
BMC Genomics; 2024 Feb; 25(1):143. PubMed ID: 38317092
[TBL] [Abstract][Full Text] [Related]
13. Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care.
Tu SM; Chen JZ; Singh SR; Aydin AM; Gokden N; Tam NNC; Leung YK; Langford T; Ho SM
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067237
[TBL] [Abstract][Full Text] [Related]
14. Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancer.
Finnegan E; Ding W; Ude Z; Terer S; McGivern T; Blümel AM; Kirwan G; Shao X; Genua F; Yin X; Kel A; Fattah S; Myer PA; Cryan SA; Prehn JHM; O'Connor DP; Brennan L; Yochum G; Marmion CJ; Das S
Cell Oncol (Dordr); 2024 Apr; 47(2):533-553. PubMed ID: 37934338
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic and molecular coordination between HDAC2 and SMAD3-SKI regulates essential brain tumour stem cell characteristics.
Bahia RK; Hao X; Hassam R; Cseh O; Bozek DA; Luchman HA; Weiss S
Nat Commun; 2023 Aug; 14(1):5051. PubMed ID: 37598220
[TBL] [Abstract][Full Text] [Related]
16. Role of Transcription Factor BEND3 and Its Potential Effect on Cancer Progression.
Naiyer S; Dwivedi L; Singh N; Phulera S; Mohan V; Kamran M
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509346
[TBL] [Abstract][Full Text] [Related]
17. Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective.
Jin ML; Jeong KW
Exp Mol Med; 2023 Jul; 55(7):1333-1347. PubMed ID: 37394580
[TBL] [Abstract][Full Text] [Related]
18. Role of Histone Deacetylases in the Pathogenesis of Salivary Gland Tumors and Therapeutic Targeting Options.
Manou M; Kanakoglou DS; Loupis T; Vrachnos DM; Theocharis S; Papavassiliou AG; Piperi C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373187
[TBL] [Abstract][Full Text] [Related]
19. Cell-of-Origin Targeted Drug Repurposing for Triple-Negative and Inflammatory Breast Carcinoma with HDAC and HSP90 Inhibitors Combined with Niclosamide.
Bhattacharya U; Kamran M; Manai M; Cristofanilli M; Ince TA
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672285
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
